Other
Neoplasm by Special Category
CI-CAN-00000004Explore in graph →
Non-malignant21,349 active trials259 approved drugs3,859 evidence items
- NCIt
- C7062
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000004Explore in graph →
Clinical trials
95,726 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00099190 | ARQ 501 in Combination With Docetaxel in Patients With Cancer | completed | Phase 1 | 50 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00234416 | IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 45 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 |
| clinicaltrials |
| NCT00242788 | IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure | completed | Phase 1 / Phase 2 | 40 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00106626 | Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors | completed | Phase 1 | 52 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Apr 22, 2009 | clinicaltrials |
| NCT00881244 | Study of AS1411 in Advanced Solid Tumours | completed | Phase 1 | 30 | Antisoma ResearchINDUSTRY | 1 | Apr 15, 2009 | clinicaltrials |
| NCT00185861 | Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma | completed | Phase 1 | 12 | Stanford UniversityOTHER | 1 | Apr 9, 2009 | clinicaltrials |
| NCT00070083 | Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma | completed | Phase 1 | — | British Columbia Cancer AgencyOTHER | 2 | Apr 7, 2009 | clinicaltrials |
| NCT00080054 | A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas | completed | Phase 1 | 24 | Pharmacyclics LLC.INDUSTRY | 1 | Apr 3, 2009 | clinicaltrials |
| NCT00102505 | A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 36 | Pharmacyclics LLC.INDUSTRY | 1 | Apr 3, 2009 | clinicaltrials |
| NCT00040573 | Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma. | completed | Phase 1 / Phase 2 | 18 | TransMolecularINDUSTRY | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00379132 | 131-I-TM-601 Study in Adults With Solid Tumors | completed | Phase 1 | 60 | TransMolecularINDUSTRY | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00695851 | Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients. | completed | Phase 1 | 36 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 30, 2009 | clinicaltrials |
| NCT00080405 | Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma | completed | Phase 1 | 40 | Millennium Pharmaceuticals, Inc.INDUSTRY | 0 | Mar 27, 2009 | clinicaltrials |
| NCT00064584 | Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML) | completed | Phase 1 | 60 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 24, 2009 | clinicaltrials |
| NCT00452257 | A Study of Enzastaurin in Patients With Leukemia | completed | Phase 1 | 18 | Eli Lilly and CompanyINDUSTRY | 1 | Mar 19, 2009 | clinicaltrials |
| NCT00863733 | Study of DMXAA (Now Known as ASA404) in Solid Tumors(DMXAA) | completed | Phase 1 | 63 | Cancer Research UKOTHER | 0 | Mar 18, 2009 | clinicaltrials |
| NCT00095108 | Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer | completed | Phase 1 | 43 | ZymoGeneticsINDUSTRY | 1 | Mar 9, 2009 | clinicaltrials |
| NCT00533728 | Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma | completed | Phase 1 | 12 | Biotec Pharmacon ASAINDUSTRY | 1 | Mar 4, 2009 | clinicaltrials |
| NCT00291473 | Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers | completed | Phase 1 | 9 | Ludwig Institute for Cancer ResearchOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00422773 | Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 21 | Technische Universität DresdenOTHER | 1 | Feb 27, 2009 | clinicaltrials |
| NCT00374179 | CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma | completed | Phase 1 | 40 | Adnexus, A Bristol-Myers Squibb R&D CompanyINDUSTRY | 1 | Feb 24, 2009 | clinicaltrials |
| NCT00848094 | Radiation Dose Escalation Study for Advanced Liver Cancer | completed | Phase 1 | 40 | Fudan UniversityOTHER | 0 | Feb 20, 2009 | clinicaltrials |
| NCT00243594 | Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection | completed | Phase 1 / Phase 2 | 40 | Radboud University Medical CenterOTHER | 1 | Feb 19, 2009 | clinicaltrials |
| NCT00847106 | Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients | completed | Phase 1 / Phase 2 | 15 | Radboud University Medical CenterOTHER | 0 | Feb 19, 2009 | clinicaltrials |
| NCT00622622 | Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer | completed | Phase 1 | 21 | Wakayama Medical UniversityOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00611000 | Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia | completed | Phase 1 | 20 | Rockefeller UniversityOTHER | 0 | Feb 17, 2009 | clinicaltrials |
| NCT00043407 | CPG 7909 in Patients Wih Stage IV Renal Cell Cancer | completed | Phase 1 / Phase 2 | 42 | PfizerINDUSTRY | 0 | Feb 12, 2009 | clinicaltrials |
| NCT00043420 | CPG 7909 in Patients With Cutaneous T-Cell Lymphoma | completed | Phase 1 / Phase 2 | 42 | PfizerINDUSTRY | 0 | Feb 12, 2009 | clinicaltrials |
| NCT00003977 | Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer | completed | Phase 1 | — | Steward St. Elizabeth's Medical Center of Boston, Inc.OTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00033410 | Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 1 | 30 | California Cancer ConsortiumNETWORK | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00331786 | Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer | completed | Phase 1 | 240 | Stony Brook UniversityOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00291538 | Comparison of Pharmacokinetics and Pharmacodynamics of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma | completed | Phase 1 | 20 | Nantes University HospitalOTHER | 1 | Feb 4, 2009 | clinicaltrials |
| NCT00832494 | Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 105 | Antisoma ResearchINDUSTRY | 0 | Jan 30, 2009 | clinicaltrials |
| NCT00086099 | Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia | completed | Phase 1 / Phase 2 | 54 | MedImmune LLCINDUSTRY | 2 | Jan 29, 2009 | clinicaltrials |
| NCT00263783 | Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors | completed | Phase 1 | 24 | MedImmune LLCINDUSTRY | 1 | Jan 29, 2009 | clinicaltrials |
| NCT00115440 | BNCT to Treat Glioma That Has Progressed Following Radiotherapy | completed | Phase 1 / Phase 2 | 22 | Boneca CorporationINDUSTRY | 1 | Jan 28, 2009 | clinicaltrials |
| NCT00252889 | Doxil Topotecan Doublet Cancer Study | completed | Phase 1 | 20 | Christiana Care Health ServicesOTHER | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00193570 | Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors | completed | Phase 1 | 20 | SCRI Development Innovations, LLCOTHER | 0 | Jan 23, 2009 | clinicaltrials |
| NCT00315861 | Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies | completed | Phase 1 | 15 | SCRI Development Innovations, LLCOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00611793 | PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies | completed | Phase 1 | 50 | SCRI Development Innovations, LLCOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00108264 | Tumor RNA Transfected Dendritic Cell Vaccines | completed | Phase 1 | — | US Department of Veterans AffairsFED | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00116896 | Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors | completed | Phase 1 | 25 | OSI PharmaceuticalsINDUSTRY | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00533533 | A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer(DO for AGC) | completed | Phase 1 / Phase 2 | 68 | Samsung Medical CenterOTHER | 1 | Jan 14, 2009 | clinicaltrials |
| NCT00820417 | Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib | completed | Phase 1 | 63 | Harrison Clinical ResearchINDUSTRY | 2 | Jan 12, 2009 | clinicaltrials |
| NCT00559429 | Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer(Tax-Sam) | completed | Phase 1 | 13 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 17, 2008 | clinicaltrials |
| NCT00157703 | G207 Followed by Radiation Therapy in Malignant Glioma | completed | Phase 1 | 9 | MediGeneINDUSTRY | 1 | Dec 16, 2008 | clinicaltrials |
| NCT00806728 | Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease | completed | Phase 1 | 17 | MedImmune LLCINDUSTRY | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00088088 | STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 86 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Dec 4, 2008 | clinicaltrials |
| NCT00088101 | STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors | completed | Phase 1 | 42 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Dec 4, 2008 | clinicaltrials |
| NCT00458250 | Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H | completed | Phase 1 | 10 | Tehran University of Medical SciencesOTHER | 1 | Nov 18, 2008 | clinicaltrials |
Data updated 23 days agoSource updated Apr 28, 2009source: clinicaltrials